Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paldeep S Atwal

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Frontiers in Medicine|August 22, 2022
Sex differences in comorbidities associated with Sjögren's diseaseKatelyn A Bruno, Andrea Carolina Morales-Lara, Edsel B Bittencourt, et al.
Research Square|February 6, 2026
Sex differences in self-reported symptoms and comorbidities associated with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A retrospective studyFrances C Wilson, Derek J Zangerle, Ashley A Darakjian, et al.
Journal of Neuropathology and Experimental Neurology|April 17, 2019
X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct DementiaPatrick R Blackburn, Wen-Lang Lin, David A Miller, et al.
American Journal of Human Genetics|April 3, 2018
Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos SyndromePatrick R Blackburn, Zhi Xu, Kathleen E Tumelty, et al.
Frontiers in Medicine|August 29, 2025
Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSDDeLisa Fairweather, Katelyn A Bruno, Ashley A Darakjian, et al.
BMC Medicine|August 18, 2021
Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort studyEden V Haverfield, Edward D Esplin, Sienna J Aguilar, et al.
BMC Medicine|November 4, 2021
Correction to: Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort studyEden V Haverfield, Edward D Esplin, Sienna J Aguilar, et al.
Human Mutation|July 12, 2016
Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular CarcinomaPatrick R Blackburn, Raymond D Hickey, Rebecca A Nace, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Mast cell score associates with wide-spread mast cell symptoms and comorbidities in patients with hEDS and HSDFrances C Wilson, Derek J Zangerle, Lincoln E Rozen, et al.
NPJ Genomic Medicine|March 27, 2024
Expanding the clinical spectrum of biglycan-related Meester-Loeys syndromeJosephina A N Meester, Anne Hebert, Maaike Bastiaansen, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Medicine|August 22, 2022
Sex differences in comorbidities associated with Sjögren's diseaseKatelyn A Bruno, Andrea Carolina Morales-Lara, Edsel B Bittencourt, et al.
Research Square|February 6, 2026
Sex differences in self-reported symptoms and comorbidities associated with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A retrospective studyFrances C Wilson, Derek J Zangerle, Ashley A Darakjian, et al.
Journal of Neuropathology and Experimental Neurology|April 17, 2019
X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct DementiaPatrick R Blackburn, Wen-Lang Lin, David A Miller, et al.
American Journal of Human Genetics|April 3, 2018
Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos SyndromePatrick R Blackburn, Zhi Xu, Kathleen E Tumelty, et al.
Frontiers in Medicine|August 29, 2025
Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSDDeLisa Fairweather, Katelyn A Bruno, Ashley A Darakjian, et al.
BMC Medicine|August 18, 2021
Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort studyEden V Haverfield, Edward D Esplin, Sienna J Aguilar, et al.
BMC Medicine|November 4, 2021
Correction to: Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort studyEden V Haverfield, Edward D Esplin, Sienna J Aguilar, et al.
Human Mutation|July 12, 2016
Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular CarcinomaPatrick R Blackburn, Raymond D Hickey, Rebecca A Nace, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Mast cell score associates with wide-spread mast cell symptoms and comorbidities in patients with hEDS and HSDFrances C Wilson, Derek J Zangerle, Lincoln E Rozen, et al.
NPJ Genomic Medicine|March 27, 2024
Expanding the clinical spectrum of biglycan-related Meester-Loeys syndromeJosephina A N Meester, Anne Hebert, Maaike Bastiaansen, et al.
Pageof 9